OncoGenex Pharmaceuticals, Inc. (OGXI) Tops Q3 EPS by 9c

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) reported Q3 EPS of ($0.40), $0.09 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $6.57 million versus the consensus estimate of $4.52 million.

For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lowe's (LOW) PT Lowered to $275 at Guggenheim
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight